Oncogenic KRAS relies on ß1 integrin expression to drive pancreatic neoplasia and PDAC development

被引：0
|
作者：
Muschler, John L.
Huang, Ge
Smith, Alexander C.
Sears, Rosalie C.
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 02期
关键词：
D O I：
10.1158/1538-7445.PANCA2023-B098
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B098
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Pancreatic and Duodenal Homeobox 1 (PDX-1) Expression in Primary Pancreatic Endocrine Neoplasia
    Alvarez, R.
    Hastings, S. M.
    Chen, J-H
    MODERN PATHOLOGY, 2010, 23 : 349A - 349A
  • [32] Pancreatic and Duodenal Homeobox 1 (PDX-1) Expression in Primary Pancreatic Endocrine Neoplasia
    Alvarez, R.
    Hastings, S. M.
    Chen, J-H
    LABORATORY INVESTIGATION, 2010, 90 : 349A - 349A
  • [33] Development of PCR assays to detect signature circulating tumor DNA methylation markers and KRas mutations for pancreatic ductal adenocarcinoma (PDAC)
    Guo, Shiwei
    Su, Mingyang
    Shi, Xiaohan
    Gao, Suizhi
    Wang, Huan
    Pan, Yaqi
    Gong, Chengxiang
    He, Qiye
    Liu, Rui
    Jin, Gang
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [34] Expression of Chosen Carcinoembryonic-Related Cell Adhesion Molecules in Pancreatic Intraepithelial Neoplasia (PanIN) Associated with Chronic Pancreatitis and Pancreatic Ductal Adenocarcinoma (PDAC)
    Zinczuk, Justyna
    Zareba, Konrad
    Romaniuk, Wioletta
    Kaminska, Dorota
    Niziol, Marcie
    Baszun, Magdalena
    Kedra, Boguslaw
    Guzinska-Ustymowicz, Katarzyna
    Pryczynicz, Anna
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2019, 16 (04): : 583 - 592
  • [35] Oncogenic KRAS Promotes Ferroptosis in Pancreatic Cancer Through Regulation of the Fosl1-Tfrc Axis
    Zhao, Huijia
    Huang, Qi
    Liu, Ying-ao
    Wu, Wenming
    PANCREAS, 2025, 54 (03) : e235 - e245
  • [36] Using single-cell RNA sequencing to assess the impact of pancreatic oncogenic Kras on macrophage gene expression in vitro
    Donahue, Katelyn
    Zhang, Yaqing
    Sirihorachai, Veerin
    The, Stephanie
    Rao, Arvind
    di Magliano, Marina Pasca
    CANCER RESEARCH, 2019, 79 (24)
  • [37] Oncogenic KRAS and p53 Loss Drive Gastric Tumorigenesis in Mice That Can Be Attenuated by E-Cadherin Expression
    Till, Jacob E.
    Yoon, Changhwan
    Kim, Bang-Jin
    Roby, Kerry
    Addai, Prince
    Jonokuchi, Evan
    Tang, Laura H.
    Yoon, Sam S.
    Ryeom, Sandra
    CANCER RESEARCH, 2017, 77 (19) : 5349 - 5359
  • [38] Ribonucleoprotein HNRNPA2B1 Interacts With and Regulates Oncogenic KRAS in Pancreatic Ductal Adenocarcinoma Cells
    Barcelo, Carles
    Etchin, Julia
    Mansour, Marc R.
    Sanda, Takaomi
    Ginesta, Mireia M.
    Sanchez-Arevalo Lobo, Victor J.
    Real, Francisco X.
    Capella, Gabriel
    Estanyol, Josep M.
    Jaumot, Montserrat
    Look, A. Thomas
    Agell, Neus
    GASTROENTEROLOGY, 2014, 147 (04) : 882 - U280
  • [39] Bmi1 combines with oncogenic KRAS to induce malignant transformation of human pancreatic duct cells in vitro
    Chen, Shao-jie
    Chen, Yin-ting
    Zeng, Lin-juan
    Zhang, Qiu-bo
    Lian, Guo-da
    Li, Jia-jia
    Yang, Ke-ge
    Huang, Chu-mei
    Li, Ya-qing
    Chu, Zhong-hua
    Huang, Kai-hong
    TUMOR BIOLOGY, 2016, 37 (08) : 11299 - 11309
  • [40] U1 Adaptors Suppress the KRAS-MYC Oncogenic Axis in Human Pancreatic Cancer Xenografts
    Tsang, Ashley T.
    Dudgeon, Crissy
    Yi, Lan
    Yu, Xin
    Goraczniak, Rafal
    Donohue, Kristen
    Kogan, Samuel
    Brenneman, Mark A.
    Ho, Eric S.
    Gunderson, Samuel I.
    Carpizo, Darren R.
    MOLECULAR CANCER THERAPEUTICS, 2017, 16 (08) : 1445 - 1455
12345